Clinical TrialID 8227

Folinic Acid for Prevention of Pemetrexed-induced Toxicity

NCT06010277

NSCLC|Mesothelioma|Thymoma

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8227
Evidence Id
8227
Core Evidence Id
8227
Source Clinical Trial Id
8225
Herb2 Clinical Trial Id
HBCT008225
Nct Id
NCT06010277
Title
Folinic Acid for Prevention of Pemetrexed-induced Toxicity
Status
Recruiting
Phase
Phase 4
Study Result
No
Study Condition
NSCLC|Mesothelioma|Thymoma
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Intervention
DRUG: Folinic acid
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
50
Outcome Measure
Difference in neutrophil count (*109/L) at day 8-10 after pemetrexed administration during 2 cycles of chemotherapy, To evaluate the haematological toxicity (continuous measure) in patients who use pemetrexed with and without rescue therapy with folinic acid., Between day 8-10 in the first 2 cycles (each cycle is 21 days)
Sponsor Collaborator
Amphia Hospital|Albert Schweitzer Hospital
Funded By
OTHER
Location
Amphia Hospital, Breda, Noord Brabant, 4817, Netherlands|Albert Schweitzer Hospital, Dordrecht, Zuid Holland, 3318, Netherlands
Other Id
1891
Start Date
2023-02-06
Primary Completion Date
2024-01
Completion Date
2024-01
First Posted
2023-08-24
Results First Posted
Last Update Posted
2023-08-24
Study Document
Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/77/NCT06010277/Prot_SAP_000.pdf
Study Url
https://clinicaltrials.gov/study/NCT06010277
Title Cn
Title En
Folinic Acid for Prevention of Pemetrexed-induced Toxicity
Bilingual Status
semi_complete